Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Genetics and Epidemiology
  • View item
  • Home
  • ICR Divisions
  • Genetics and Epidemiology
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Runs of homozygosity and testicular cancer risk.

Thumbnail
View/Open
Accepted version (548.9Kb)
Date
2019-07
ICR Author
Loveday, Chey
Huddart, Robert
Sud, Amit
Turnbull, Clare
Houlston, Richard
Eeles, Rosalind
Kote-Jarai, Zsofia
Broderick, Peter
Rustin, Gordon
Show allShow less
Author
Loveday, C
Sud, A
Litchfield, K
Levy, M
Holroyd, A
Broderick, P
Kote-Jarai, Z
Dunning, AM
Muir, K
Peto, J
Eeles, R
Easton, DF
Dudakia, D
Orr, N
Pashayan, N
UK Testicular Cancer Collaboration
PRACTICAL Consortium
Reid, A
Huddart, RA
Houlston, RS
Turnbull, C
Show allShow less
Type
Journal Article
Metadata
Show full item record
Abstract
Background Testicular germ cell tumour (TGCT) is highly heritable but > 50% of the genetic risk remains unexplained. Epidemiological observation of greater relative risk to brothers of men with TGCT compared to sons has long alluded to recessively acting TGCT genetic susceptibility factors, but to date none have been reported. Runs of homozygosity (RoH) are a signature indicating underlying recessively acting alleles and have been associated with increased risk of other cancer types.Objective To examine whether RoH are associated with TGCT risk.Methods We performed a genome-wide RoH analysis using GWAS data from 3206 TGCT cases and 7422 controls uniformly genotyped using the OncoArray platform.Results Global measures of homozygosity were not significantly different between cases and controls, and the frequency of individual consensus RoH was not significantly different between cases and controls, after correction for multiple testing. RoH at three regions, 11p13-11p14.3, 5q14.1-5q22.3 and 13q14.11-13q.14.13, were, however, nominally statistically significant at p < 0.01. Intriguingly, RoH200 at 11p13-11p14.3 encompasses Wilms tumour 1 (WT1), a recognized cancer susceptibility gene with roles in sex determination and developmental transcriptional regulation, processes repeatedly implicated in TGCT aetiology.Discussion and conclusion Overall, our data do not support a major role in the risk of TGCT for recessively acting alleles acting through homozygosity, as measured by RoH in outbred populations of cases and controls.
URI
https://repository.icr.ac.uk/handle/internal/3339
DOI
https://doi.org/10.1111/andr.12667
Collections
  • Genetics and Epidemiology
  • Radiotherapy and Imaging
Subject
UK Testicular Cancer Collaboration
PRACTICAL Consortium
Humans
Neoplasms, Germ Cell and Embryonal
Testicular Neoplasms
Risk Factors
Genotype
Homozygote
Polymorphism, Single Nucleotide
Genome
Male
Genome-Wide Association Study
Research team
Cancer Genomics
Clinical Academic Radiotherapy (Huddart)
Oncogenetics
Language
eng
Date accepted
2019-05-17
License start date
2019-07
Citation
Andrology, 2019, 7 (4), pp. 555 - 564

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.